View of Preclinical Evaluation of CLX-155A: A Novel 5-FU and Valproic Acid Pro-drug in Nude Mouse Model for Activity in Triple-Negative Breast Cancer

Return to Article Details Preclinical Evaluation of CLX-155A: A Novel 5-FU and Valproic Acid Pro-drug in Nude Mouse Model for Activity in Triple-Negative Breast Cancer Download Download PDF